Market Place
Sourcing Support
FDA Cites Firms for CGMP Violations; Unapproved Drugs Sold Online
31 Jul 2025 //
RAPS
AIOCD Demands Strict Action Against Illegal E-Pharmacies
27 Jul 2025 //
ECONOMICTIMES
Sun Pharma, Lupin, Dr Reddy`s Recall Products in US
27 Jul 2025 //
ECONOMICTIMES
Counterfeit Dental Products Raise Safety Concerns
26 Jul 2025 //
PHARMABIZ
Indoco`s Goa Plant II Gets Eu Gmp Compliance-Certified
24 Jul 2025 //
EXPRESSPHARMA
FDA Eyeing Study Requirements to Confirm Elevidys Safety: Report
24 Jul 2025 //
FIERCE BIOTECH
FDA Warns Glenmark for Not Probing Dissolution Failures
23 Jul 2025 //
RAPS
NIH Budget Cuts, Slower Fda Reviews to Significantly Impact Drug
22 Jul 2025 //
RAPS
Körber adds Bizerba to PAS-X Weigh & Dispense Technology Partner
21 Jul 2025 //
CONTRACTPHARMA
Dr Reddy Gets 7 USFDA Observations After Plant Inspection
20 Jul 2025 //
BUSINESS STD
USFDA issues Lupin Form 483 citing 4 observations for Pithampur
18 Jul 2025 //
INDPHARMAPOST
Pfizer Warns of Penicillin Product `stock Out` Following Recall
17 Jul 2025 //
FIERCE PHARMA
USFDA grants VAI status to SMS lifesciences` kazipally API
17 Jul 2025 //
INDPHARMAPOST
Shilpa Medicare receives EIR from USFDA for Unit VI, Bengaluru
17 Jul 2025 //
INDPHARMAPOST
FDA Urged to Remove Boxed Warning on Women`s Hormone Therapy
17 Jul 2025 //
RAPS
Emcure Rises as USFDA Issues Form 483 With Zero Observations
10 Jul 2025 //
BUSINESS STD
Telangana DCA Intensifies Anti-Counterfeit Drug Drive, Arrests
10 Jul 2025 //
PHARMABIZ
Pharmexcil Alerts Exporters On Botswana Inspection Rule
10 Jul 2025 //
PHARMABIZ
Granules India recalls 33,000 bottles of blood lowering drug
09 Jul 2025 //
ECONOMICTIMES
Sun Pharma Works to Resolve USFDA Issues at 3 Plants
08 Jul 2025 //
ECONOMICTIMES
China Retaliates with Import Restrictions on Medical Devices
06 Jul 2025 //
REUTERS
Sigachi Updates on Fire at Pashamylaram Telangana Plant
04 Jul 2025 //
INDPHARMAPOST
Pharma Industry Seeks Secure Graphics, Data Protection Against
04 Jul 2025 //
PHARMABIZ
Indian Healthcare Grapples with Illegible Prescriptions
03 Jul 2025 //
PHARMABIZ
FDA Cites STI Failures, Dirty Facilities, and Dosing Abuse
01 Jul 2025 //
#N/A
Govt to Bring in Barcodes to Fight Fake Drug Menace
27 Jun 2025 //
ECONOMICTIMES
Plans to Restrict Open Market Access to Tuberculosis Medicines
27 Jun 2025 //
ECONOMICTIMES
Aurobindo Pharma recalls 4,608 pain reliever bottles in US
27 Jun 2025 //
ECONOMICTIMES
CDC Panel Recommends Against Use of Thimerosal in Flu Vaccines
27 Jun 2025 //
FIERCE PHARMA
Pondicherry Pharma MSMEs Face Deadline in CDSCO`s cGmp Crackdown
26 Jun 2025 //
PHARMABIZ
FDA Warns Sterling Distributors for DSCSA Compliance Issues
25 Jun 2025 //
RAPS
Glenmark’s Facility Gets 5 FDA Observations Post-Inspection
24 Jun 2025 //
THEHINDU
Gland Pharma Gets USFDA EIR for Visakhapatnam Facility
24 Jun 2025 //
BUSINESS STD
Concord Biotech`s API facility completes USFDA inspection
24 Jun 2025 //
CAPTICALMRKT
Fixing Extractables & Leachables Studies for Regulatory Review
23 Jun 2025 //
EXPRESSPHARMA
Unichem Gets Form 483 from USFDA for Roha API Facility
23 Jun 2025 //
INDPHARMAPOST
Granules India receives Form 483 with 1 observation from USFDA
23 Jun 2025 //
INDPHARMAPOST
DGTR to Hold Oral Hearing On Anti-dumping Investigation
21 Jun 2025 //
PHARMABIZ
USFDA ends inspection at Zydus` oncology plant in Ahmedabad
20 Jun 2025 //
INDPHARMAPOST
Aurora Cannabis Warns of Another False Article from Investing.com
19 Jun 2025 //
PR NEWSWIRE
USFDA issues Form 483 with 7 observations to Natco Hyderabad
19 Jun 2025 //
ECONOMICTIMES
Alembic Pharmaceuticals gets USFDA EIR for API-III in Gujarat
19 Jun 2025 //
EXPRESSPHARMA
New Import Rules May Boost Pharma Imports with Gold Restrictions
19 Jun 2025 //
PHARMABIZ
Glenmark Pharma`s NC facility receives five FDA observations
18 Jun 2025 //
THE HINDU
Lawsuit Challenges FTC Authority on `unsubstantiated` Ad Claims
18 Jun 2025 //
REUTERS
Sun Pharma`s Halol plant receives 8 observations from US FDA
14 Jun 2025 //
MONEYCONTROL
Regulators ask NITI Aayog to set up Task Force on fake drugs
14 Jun 2025 //
PHARMABIZ
Senators Lead Push to Ban DTC ads For Prescription Drugs
13 Jun 2025 //
FIERCE PHARMA
USFDA inspection at API manufacturing plant located in Mekaguda
13 Jun 2025 //
INDPHARMAPOST
MSP Law Firm Sues FYI Yachts, Ralph Navarro for Racketeering
13 Jun 2025 //
GLOBENEWSWIRE
Capricor reports FDA inspection findings on Form 483
11 Jun 2025 //
TIPRANKS
Capricor Therapeutics Announces Regulatory Updates for DMD
11 Jun 2025 //
GLOBENEWSWIRE
FDA Warns Sprout Over Addyi Instagram Post, Lacking Ind
11 Jun 2025 //
RAPS
OneSource Specialty Pharma`s Bangalore facility maintains US FDA
10 Jun 2025 //
#N/A
New York, States Urge FDA to Expand Access to Abortion Pill
09 Jun 2025 //
REUTERS
Spurious Drugs Seized from Habitual Offender in Hyderabad
07 Jun 2025 //
PHARMABIZ
Four States Ask FDA to Lift Restrictions on Mifepristone
07 Jun 2025 //
FIERCE PHARMA
FDA Warns Firms for Inadequate Testing, BIMO Violations
06 Jun 2025 //
RAPS
ASPA Commissions 2nd Edition of Counterfeiting Report
06 Jun 2025 //
EXPRESSPHARMA
Smiths Medical Recalls Infusion Pumps over 3 Safety Risks
05 Jun 2025 //
FIERCE BIOTECH
